E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers M > Headlines for Mirati Therapeutics, Inc. > News item
Published on 10/16/2013 in the Prospect News PIPE Daily.

Mirati Therapeutics to price public sale of 3 million common shares

Offering will be conducted by Jefferies, Leerink Swann, Piper Jaffray

By Devika Patel

Knoxville, Tenn., Oct. 16 - Mirati Therapeutics, Inc. said it will sell 3 million common shares in a public offering with a30-day, 15% greenshoe.

Jefferies LLC and Leerink Swann LLC are the joint bookrunning managers. Piper Jaffray & Co. is the lead manager.

The targeted oncology company is based in San Diego.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.